North Park University Receives NIH Grant for Lymphoma Research

North Park University (NPU) in Chicago has reached a significant milestone by securing its first-ever grant from the National Institutes of Health (NIH) on September 17, 2026. The grant, totaling $650,108, is allocated for a four-year research project led by Assistant Professor Dr. Tracy O’Connor. This funding is part of the NIH Support for Research Excellence (SuRE) program, which aims to enhance research capacity at educational institutions that traditionally receive limited NIH funding. The project, titled "Mechanisms of Lymphoma Cell Dissemination to the Brain," seeks to understand how lymphoma cells exploit chemokine networks and signaling pathways to migrate to the brain. The research is expected to inform treatment strategies to prevent lymphoma from spreading to the nervous system, thus making an impact on cancer care.

The NIH SuRE program is designed to assist faculty at eligible institutions that are not currently funded by any NIH grant, aside from SuRE or SuRE-First awards. By receiving this grant, North Park University joins a select group of 20 universities in Illinois awarded NIH funding for the 2026 fiscal year. This recognition not only underscores the university's research efforts but also signifies a growing commitment to enhancing research capabilities within institutions that may have limited funding histories. Dr. O’Connor expressed enthusiasm about the grant, stating, "This award will significantly expand opportunities for directed and summer research in the biomedical sciences at North Park."

The funding will provide students with hands-on research experiences, fostering their skills and preparing them for future careers in biomedical and behavioral sciences. The collaboration between students and faculty is expected to strengthen the community of learning at NPU, contributing to a richer educational environment. The broader implications of this research extend beyond the university itself. By exploring how lymphoma cells invade the brain, the study aims to uncover critical insights that could lead to improved treatment options for patients. This aligns with ongoing efforts in the medical community to enhance cancer care and develop more effective therapies.

Additionally, the project adds to the growing body of knowledge in cancer research, which is vital for advancing public health outcomes. As the project began on September 24, 2026, and is set to run until August 31, 2030, the research efforts at North Park University are poised to make significant contributions to the field of cancer research. The findings could pave the way for innovative approaches to combat lymphoma and improve patient care. The success of this initiative may also encourage further investment in research at institutions like NPU, highlighting the importance of supporting diverse educational environments in the pursuit of scientific advancement and better health outcomes.